TMO
52
8
PSA
43
6
UA
48
6
HAS
29
3
CA
19
6
CFG
36
12
MU
42
14
TGT
35
4
ABBV
40
5
O
26
16
VNO
46
6
CMI
49
2
ADT
12
2
APH
53
3
JPM
59
6
WMB
58
3
MAS
46
3
BK
60
2
AXP
63
3
PWR
63
3
TMO
52
8
PSA
43
6
UA
48
6
HAS
29
3
CA
19
6
CFG
36
12
MU
42
14
TGT
35
4
ABBV
40
5
O
26
16
VNO
46
6
CMI
49
2
ADT
12
2
APH
53
3
JPM
59
6
WMB
58
3
MAS
46
3
BK
60
2
AXP
63
3
PWR
63
3
Financhill
Back

Keros Therapeutics Vs. Trevi Therapeutics Industry Stock Comparison

Sell
4

KROS
Keros Therapeutics

Last Price:
$17.04
Seasonality Move:
16.43%
Sell
50

TRVI
Trevi Therapeutics

Last Price:
$4.06
Seasonality Move:
52.76%
Sell
4
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $17.03. The Score for KROS is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
50
Trevi Therapeutics (TRVI) is a Sell

Is Trevi Therapeutics a Buy, Sell or Hold?

  • The current Trevi Therapeutics [TRVI] share price is $4.05. The Score for TRVI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • TRVI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $17.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

TRVI Stock Price Chart

What is Trevi Therapeutics's stock price today?

  • The Trevi Therapeutics share price today is $4.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.49 Sell
Relative Strength Index (14 RSI): 22.6 Sell
Chaikin Money Flow: -285503 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.79 - 67.83) Sell
Bollinger Bands (100): (41.67 - 65.17) Sell

TRVI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 64.87 Buy
Chaikin Money Flow: -1741528 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.52 - 3.78) Buy
Bollinger Bands (100): (2.7 - 3.44) Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.3 Sell
20-day SMA: 46.77 Sell
50-day SMA: 55 Sell
200-day SMA: 53.85 Sell
8-day EMA: 25.85 Sell
20-day EMA: 40.07 Sell
50-day EMA: 49.85 Sell
200-day EMA: 51.91 Sell

TRVI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.92 Buy
20-day SMA: 3.24 Buy
50-day SMA: 3.11 Buy
200-day SMA: 2.97 Buy
8-day EMA: 3.89 Buy
20-day EMA: 3.46 Buy
50-day EMA: 3.2 Buy
200-day EMA: 2.88 Buy

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.20 per share.

Trevi Therapeutics Earnings Growth & TRVI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):